Changes of body immunity and inflammatory response in HIV/HCV co-infected patients
- PMID: 30651812
- PMCID: PMC6307362
- DOI: 10.3892/etm.2018.6938
Changes of body immunity and inflammatory response in HIV/HCV co-infected patients
Abstract
Changes of body immunity and inflammatory response in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infected patients were investigated. Eighty HIV/HCV infected patients admitted to Qingdao No. 6 People's Hospital from August 2015 to December 2017 were selected and divided into two groups according to whether they were complicated with HCV infection or not (n=40 per group). The changes of the related humoral immune indexes, the related cellular immune indexes, the related indexes of hepatic function, the related indexes of inflammatory response in the two groups were compared, and the correlations of high-sensitivity C-reactive protein (hs-CRP) level with alanine aminotransferase (ALT) level, immunoglobulin G (IgG) level and cluster of differentiation 4+ (CD4+) level in the observation group were analyzed. The levels of related humoral immune indexes [immunoglobulin G (IgG), IgA and IgM levels], the related cellular immune indexes (CD4+ and CD8+) in the observation group were lower than those in the control group (P<0.05), and the CD4+/CD8+ ratio in the observation group was lower than that in the control group (P<0.05). The levels of indexes of hepatic function [ALT, aspartate aminotransferase (AST) and total bilirubin] in the observation group were significantly higher than those in the control group (P<0.05). The levels of hs-CRP, interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) in the observation group were significantly higher than those in the control group (P<0.05). There were positive correlations of hs-CRP level with ALT level and IgG level in the observation group (P<0.05). There was a negative correlation between hs-CRP level and CD4+ level in the observation group (P<0.05). The humoral and cellular immune functions of the HIV/HCV co-infected patients are significantly limited, their hepatic function is significantly impaired and the levels of inflammatory cytokines are markedly increased. The level of hs-CRP is positively correlated with hepatic function and humoral immune function and negatively correlated with cellular immune function.
Keywords: HCV infection; HIV infection; cellular immunity; hepatic function; humoral immunity; inflammatory response.
Figures



Similar articles
-
Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.BMC Immunol. 2013 May 17;14:23. doi: 10.1186/1471-2172-14-23. BMC Immunol. 2013. PMID: 23679118 Free PMC article.
-
Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.Comput Intell Neurosci. 2022 Aug 23;2022:6336107. doi: 10.1155/2022/6336107. eCollection 2022. Comput Intell Neurosci. 2022. Retraction in: Comput Intell Neurosci. 2023 Aug 2;2023:9817406. doi: 10.1155/2023/9817406. PMID: 36052044 Free PMC article. Retracted.
-
Correlation of vitamin D with inflammatory factors, oxidative stress and T cell subsets in patients with autoimmune hepatitis.Exp Ther Med. 2020 May;19(5):3419-3424. doi: 10.3892/etm.2020.8601. Epub 2020 Mar 12. Exp Ther Med. 2020. PMID: 32266042 Free PMC article.
-
The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection.J Res Med Sci. 2015 Feb;20(2):127-32. J Res Med Sci. 2015. PMID: 25983763 Free PMC article.
-
Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis.J BUON. 2019 Nov-Dec;24(6):2411-2417. J BUON. 2019. PMID: 31983113
Cited by
-
Preliminary investigation of relationship between clinical indicators and CT manifestation patterns of COVID-19 pneumonia improvement.J Thorac Dis. 2020 Oct;12(10):5896-5905. doi: 10.21037/jtd-20-1420. J Thorac Dis. 2020. PMID: 33209422 Free PMC article.
-
Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.Clin Cardiol. 2020 Mar;43(3):222-234. doi: 10.1002/clc.23299. Epub 2019 Nov 30. Clin Cardiol. 2020. PMID: 31785111 Free PMC article. Review.
-
Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study.Pharmaceuticals (Basel). 2024 Aug 30;17(9):1152. doi: 10.3390/ph17091152. Pharmaceuticals (Basel). 2024. PMID: 39338314 Free PMC article.
References
-
- Mínguez C, García-Deltoro M, Flores J, Galindo MJ, Montero M, Reus S, Carmena J, Masiá M, Amador C, Ortega E. on the behalf of the COINFECOVA-2 study group: Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients. AIDS. 2018;32:337–346. - PubMed
-
- Tavitian-Exley I, Maheu-Giroux M, Platt L, Heimer R, Uusküla A, Levina O, Vickerman P, Boily MC. Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia. Int J Drug Policy. 2018;53:96–105. doi: 10.1016/j.drugpo.2017.11.010. - DOI - PubMed
-
- Kim YC, Ahn JY, Kim JM, Kim YJ, Park DW, Yoon YK, Song JY, Kim SW, Lee JS, Choi BY, et al. Human immunodeficiency virus (HIV) and hepatitis virus coinfection among HIV-infected Korean patients: The Korea HIV/AIDS cohort study. Infect Chemother. 2017;49:268–274. doi: 10.3947/ic.2017.49.3.194. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous